unknown
Stage
1
Investors
About
Epi Biologics is listed in the Novartis Venture Fund portfolio as a life‑science company, indicating it operates in the biotechnology/biopharma space and is likely focused on developing therapeutics or therapeutic platforms.
Explore Epi Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.